Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
Jean Endicott,1 Henrik Svedsäter,2 Julie C Locklear21Department of Psychiatry, Columbia University, New York, NY; 2AstraZeneca Pharmaceuticals, Wilmington, DE, USABackground: We evaluated the effects of once-daily extended-release quetiapine fumarate (quetiapine XR) on patient-reported...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2012
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/4c48c3d25c844b1dbba96802ad7b0b38 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|